GL1X · GenesisL1 explorer

MolNFT v1 · #86268 · protein

New aminoimidazoles as bace-1 inhibitors: from rational design to ab- lowering in brain

4B1D · Beta-secretase 1: “New aminoimidazoles as bace-1 inhibitors: from rational design to ab- lowering in brain”. X-ray diffraction, 1 ligand (6TG), 2 pockets (best druggability 0.69). MolNFT v1 #86268 on GenesisL1: 3D structure, binding…

PDB
4B1D
Type
protein
Length
376 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
6TG
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 16% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein37616% helix, 42% strandP56817

Ligands and binding sites

  • 6TG · (2S)-2-(4-methoxy-3,5-dimethylphenyl)-5-methyl-2-(3-pyrimidin-5-ylphenyl)-2H-imidazol-4-amine · ligand · chains A
  • ACT · Acetate ion · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16680.690.7765ACT, 6TG
2620.320.7618empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 4B1D · New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.